Portosystemic Shunt Related Parkinsonism in Acquired Hepatocerebral Degeneration With Persistent Pallidal T1 Hyperintensity
Objective: To highlight acquired hepatocerebral degeneration as an underrecognized cause of secondary parkinsonism and to emphasize the diagnostic value of serial MRI in movement disorder…Prediction of Cognitive Decline After STN-DBS in Parkinson’s Disease Using Preoperative Electroencephalography and a Deep Learning Model
Objective: To determine whether preoperative electroencephalography (EEG) combined with deep learning can predict cognitive decline 1 year after subthalamic deep brain stimulation (STN-DBS) in patients…Military-related associations with Parkinson’s disease (PD) in the Millenium Cohort Study
Objective: To examine associations between military-related exposures and PD. Background: The Millennium Cohort Study is a large prospective cohort of 260,228 US service members and…Immune-mediated Chorea in Antiphospholipid Syndrome: Normalization of FDG-PET and Neurofilament as Markers of Treatment Response.
Objective: To present a case where FDG-PET and neurofilament findings help portray the reversibility of neuronal damage in antiphospholipid syndrome (aPL). Background: Chorea is the most common movement disorder in aPL and often an initial manifestation, although…Subthalamic Nucleus Deep Brain Stimulation Modulates Cortical Activation During Kinesthetic Illusion in Parkinson’s Disease: An fMRI Study
Objective: To investigate how subthalamic nucleus deep brain stimulation (STN-DBS) modulates cortical activation during kinesthetic illusion (KI) in Parkinson’s disease (PD). Background: There is increasing…Medication Burden and Associated Challenges for People with Parkinson’s: A Survey of 359 UK Patients
Objective: To quantify medication burden among people with Parkinson’s disease (PD) and explore factors which contribute to medication experience in PD. Background: Individualised, complex medication…Iron-independent initiation of neurodegeneration in BPAN
Objective: Beta-propeller protein–associated neurodegeneration (BPAN) is caused by mutations in WDR45 and classified within the neurodegeneration with brain iron accumulation (NBIA) spectrum. Although brain iron…Exploratory Results From a Phase 1 Study of NIO752 in Progressive Supranuclear Palsy Supporting Further Clinical Studies
Objective: To report exploratory analyses of biomarker and clinical outcomes from a first-in-human study of NIO752 in progressive supranuclear palsy (PSP) and provide rationale for…Perception of Early-Intervention Therapies and Clinically Meaningful Delays in Huntington’s Disease Onset and Progression: The Pre-HDBOI Study
Objective: To characterize willingness among people with premanifest Huntington’s disease (PwPHD) to consider early-intervention therapies if available, the minimally acceptable delay in HD onset/progression, and…Real-world database analysis of new-onset hypotension and medications for orthostatic hypotension prescribing patterns in patients with Parkinson’s Disease receiving MAO-B Inhibitors and levodopa in Japan
Objective: To evaluate the incidence of claims-defined new-onset hypotension and the prescribing patterns of medications for orthostatic hypotension in patients with Parkinson’s disease (PD) treated…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 1942
- Next Page »
